Tesamorelin

The stabilized GHRH analog

Listed strength: 20 mg
Mol. weight: 5136 g/mol
Residues: 44
Class: GHRH analog (secretagogue)

$110

20 mg lyophilized vial$5.50/mg · research use only

Reference specifications publishedResearch use only

Research use only · no human or veterinary use, consumption, administration, diagnosis, treatment, prevention, cosmetic use, or food use. Sold to qualified laboratory and analytical users.

Overview

Tesamorelin is a 44-residue analog of growth-hormone-releasing hormone (GHRH). The catalogue lists a 20 mg lyophilized format.

Mechanism (research literature)

Tesamorelin is classified by its interaction with the GHRH receptor. Its analog structure distinguishes it from native GHRH.

Research context

Tesamorelin appears in endocrine and GHRH-receptor literature.

Specification

Listed format20 mg lyophilized vial

Sequence44-residue GHRH analog

Molecular formulaC221H366N72O67S

Molecular weight5136 g/mol

Catalogue referenceAGX-06

Listed price$110

Size44 residues

TargetPituitary GHRH receptor

Common questions

What is GHRH?

GHRH abbreviates growth-hormone-releasing hormone.

What does analog mean here?

It identifies a molecule structurally related to GHRH, with modifications to that structure.

Learn how to read a catalogue record ↗

Lot documentation status ↗